Evidence map›Paper›PMID 42215914›Full record

ReviewBMC infectious diseases2026

A successful individualized comprehensive therapy for carbapenem-resistant Klebsiella pneumoniae induced multifocal brain abscesses: a case report and literature review.

Boyuan Huang, Minglu Yuan, Mengyang Wang, Gengsheng Mao, Lin Chen

Abstract readCase ReportsReview
In one paragraph

Review in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Boyuan Huang *Second Department of Neurosurgery, Beijing Electric Power Hospital of State Grid Corporation of China, Capital Medical University Electric Power Teaching Hospital, Beijing, China. 525111209@qq.com.
Minglu Yuan *Department of Pharmacy, Beijing Electric Power Hospital of State Grid Corporation of China/Capital Medical University Electric Power Teaching Hospital, Beijing, China.
Mengyang WangSecond Department of Neurosurgery, Beijing Electric Power Hospital of State Grid Corporation of China, Capital Medical University Electric Power Teaching Hospital, Beijing, China.
Gengsheng MaoSecond Department of Neurosurgery, Beijing Electric Power Hospital of State Grid Corporation of China, Capital Medical University Electric Power Teaching Hospital, Beijing, China.
Lin ChenSecond Department of Neurosurgery, Beijing Electric Power Hospital of State Grid Corporation of China, Capital Medical University Electric Power Teaching Hospital, Beijing, China. ChenLin_china@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant Klebsiella pneumoniae (CRKP)-induced brain abscess is an exceedingly rare disease. We presented the fourth case of CRKP-induced brain abscess but the first multifocal and most complicated one accompanied by intracranial Epstein-Barr virus detection positive. The patient was treated with a regime of intravenous ceftazidime/avibactam combined with intrathecal colistimethate sodium. To our knowledge, this represented the first reported application of such a regimen for a CRKP-induced brain abscess. When the abscess formed an intact envelope, the patient underwent craniotomy for resection. Postoperatively, the antibiotic regimen was continued for 2 weeks until the CSF examination became nearly normal. The patient remained asymptomatic over the next 12 months follow-up without recurrences. This case highlights the rarity of CRKP-induced brain abscess and provides a novel combination of antibiotic regimen, which also emphasizes the necessity for individualized and comprehensive therapeutic strategy.

Indexed as

Anti-Bacterial AgentsBrain AbscessCarbapenem-Resistant EnterobacteriaceaeKlebsiella InfectionsKlebsiella pneumoniaeAzabicyclo CompoundsCarbapenemsCeftazidimeColistinDrug CombinationsHumansMaleTreatment OutcomeAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsCarbapenemsCeftazidimeColistinDrug CombinationsCarbapenem-resistant Klebsiella pneumoniaeCeftazidime/avibactamColistimethate sodiumMultifocal brain abscesses

Identifiers

PMID42215914
PMCPMC13425769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.